Casebia Therapeutics

Among the many innovative new medicines launched in 2023, one approval stands out in terms of innovation – Vertex and CRISPR Therapeutics ’ sickle cell and beta thalassemia gene therapy Casgevy, th

Bayer AG 's freshly-inked CAR-T alliance with Atara Biotherapeutics, Inc. is another key piece in the German company's strategy of establishing itself as a leading player in the emerging fields of g

The US presidential election slowed the flow of venture capital funding announcements during the first week of November, but the flood of new biopharmaceutical VC deals resumed during the second week

Leading the charge with a simple mantra “we do science well” is Bayer Pharmaceuticals’ president for the Americas, Sebastian Guth, a 45-year-old management PhD who took the position just a year ago af